Drug firms finance Europe’s patient groups with multi-million donations

Pharmaceutical industry pours €110 million into advocacy organisations across the continent, Investigate Europe research reveals. Critics argue that funding threatens “independence” of the sector, claims that are rejected by groups.

16 September 2024

Chris Matthews, Manuel Rico, Lorenzo Buzzoni

Big pharma influence hangs over Europe’s medicines regulator

Investigate Europe has found that the European Medicines Agency is beset by several conflict of interest concerns over professional and financial ties to industry. It is also facing growing criticism for fast-tracking drugs that could pose serious risks to patients.

17 June 2024

Leïla Miñano, Maria Maggiore, Manuel Rico, Catrien Spijkerman

Medicine dealers: Europe’s secret drug negotiations

Confidential agreements, secret discounts and the power of big pharma. Inside the opaque word of Europe's hidden drug pricing system.

13 June 2024

Eurydice Bersi (Reporters United), Lorenzo Buzzoni, Maxence Peigné

Cross-border stories from a changing Europe, in your inbox.

Featured Articles

Our themes

HELP US CONNECT THE DOTS ON EUROPE

Support cross-border journalism